Chandreshwar P. Shukla

A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer

M. O'Donnell, B. Chakraborty, R. Sood, 2019, Bladder Cancer.

DESMOCOLLIN 3 GENE (DSC3) EXPRESSION AND CANCER - IN SILICO EVALUATION

N. Jain, B. Khamar, R. Modi, 2020, Journal of Bio Innovation.